EUCTR2007-001783-75-SE进行中（未招募）不适用
Phase 2 trial with Avastin and Doxorubicin postoperatively for patients with anaplastic thyroid carcinoma
Department of Oncology, Lund University Hospital0 个研究点目标入组 30 人开始时间: 2008年1月11日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Verified anaplastic thyroid cancer.
- •Completion of standard initial therapy with radiotherapy and chemotherapy
- •Surgically resected with macroscopic radicality
- •Performance Status ECOG 0-2. If lung metastasis ECOG 0-1
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Performance Status ECOG 3-4. If lung metastasis ECOG 2-4
- •Macroscopic evident non-radical surgery.
研究者
相似试验
终止
2 期
Phase II Study of Doxorubicin and Avastin® in Sarcoma.Soft Tissue SarcomaSarcomaNCT00755261Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
终止
2 期
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine TumorsPancreatic CancerNCT00609765H. Lee Moffitt Cancer Center and Research Institute1
已完成
2 期
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum CarcinomaFallopian Tube CancerMalignant Tumor of PeritoneumOvarian CancerNCT00504257H. Lee Moffitt Cancer Center and Research Institute45
已完成
不适用
A randomised phase II study of doxorubicin combined with thalidomide versus doxorubicin alone for patients with unresectable hepatocellular carcinomaCancerISRCTN53872240Erasmus Medical Centre (Netherlands)30
已完成
2 期
A phase II trial of PAD (Bortezomib, Doxorubicin and Dexamethasone) induction therapy in transplant-eligible patients with untreated multiple myeloma (MM), stratified for markers of bortezomib resistance.Cancer - MyelomaMultiple MyelomaACTRN12609000296235Janssen-Cilag Pty Ltd107